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ABSTRACT Intact erythrocytes become immediately crenated upon addition of 2,4-dinitrophenol
(DNP) or pyrenebutyric acid (PBA) . However, when cells are incubated at 37°C in the presence of the
crenating agents with glucose, they gradually (4-8 h) recover the normal biconcave disc form . The
recovery process does not reflect a gradual inactivation of DNP or PBA since fresh cells are equally
crenated by the supernatant from the recovered cells . Further, after recovery and removal of the
crenating agents, cells are found to be desensitized to the readdition of DNP as well as to the addition
of PBA, but they are more sensitive to cupping by chlorpromazine . This alteration in the cell
\membrane responsiveness was reversible upon further incubation in the absence of DNP. Recovery
s dependent upon cellular metabolic state since an energy source is needed and incubation with
uanosine but not adenosine will accelerate conversion to the disc shape . It is suggested that the
conversion of cells from crenated to disc shape in the presence of the crenators, represents an
alteration or rearrangement of membrane components rather than a redistribution of the crenators
within the membrane . This shape recovery process may be important for erythrocyte shape preser-
vation as well as shape control in other cells .
The morphology of eukaryotic cells provides a visual manifes-
tation of many cell properties and is a valuable indicator of
cell state. For example, the complex morphological changes in
cell adhesion and spreading are correlated with an alteration
of protein synthesis (1) . In human erythrocytes, cell shape
change is an indication of a major dysfunction and is normally
associated with hemolysis (2-4).
Because the erythrocyte lacks organelles or structured cyto-
plasmic elements, its morphology is determined by the cell
volume and the plasma membrane properties. Under isovol-
umic conditions, erythrocytes will normally become either
echinocytes (crenated cells) or stomatocytes (cupped cells)
when the shape is perturbed . The crenation of erythrocytes is
similar to the formation ofmany long villi during the rounding
of eukaryotic cells since both involve an increase in the relative
area of the outside surface of the membrane over that of the
inner surface as described by the bilayer couple hypothesis (5) .
In any closed membrane surface, the relative area of the inner
vs . outer membrane surface is an important factor in determin-
ing cell morphology . Because of the relative simplicity of the
erythrocyte membrane, the mechanisms of membrane shape
control can be studied apart from the influence of cytoplasmic
structures .
The erythrocyte biconcave disc shape is normally preserved
for its 120 - d life-span in vivo, despite the fact that its mem-
brane shape is extremely susceptible to morphological changes
when exposed to a variety of mild treatment conditions in vitro
(6), which may occur in vivo as well. This suggests that the
erythrocyte might possess a system for sensing alterations in
shape and correcting them . We have indeed found that mild
crenation caused by amphipathic agents can be reversed by a
process that appears to involve the alteration of membrane
properties.
MATERIALS AND METHODS
Materials
BLOOD :
￿
Human erythrocytes were drawn from healthy donors into heparin-
ized tubes. Cells were then washed three times in phosphate-buffered saline
(PBS) buffer (130mM NaCl, 9mM Na2HPO,), pH 7.4, which contained 10mM
glucose . Cells were used for experiments within 2-4 h after washing .
CHEMICALS:
￿
2,4-Dinitrophenol (DNP) was obtained from Sigma Chemical
Co . (St. Louis, Mo .) and I-pyrenebutyric acid (PBA) from Eastman Organic
Chemicals . DNP and PBA were recrystallized from ethanol-water three times
before use . Chlorpromazine was obtained from Sigma Chemical Co . [3H]DNP
was purchased from New England Nuclear (Boston, Mass.) . Reagents were
prepared in PBSand adjusted to pH 7.4 before use . All other chemicals were the
best available grade from commercial sources .
Methods
All incubations of erythrocytes (5% hematocrit) with various agents were
conducted at 37°C in PBS containing 10 mM glucose . Cells were preincubated
for 1 h at 37°C in PBS-glucose before addition of the reagents. Incubations were
stopped by adding four parts of cellsuspension toone part o£ 10% glutaraldehyde
THE JOURNAL OF CELL BIOLOGY " VOLUME 91 DECEMBER 1981 884-888
©The Rockefeller University Press - 0021-9525/81/12/0884/05 $1.00in PBS. The initial extent of crenation (0h) was determined by mixing the cell
suspension with glutaraldehyde within 3-5 s after adding in crenating agent
(37°C) . Samples were cooled to 0°C for 1 h before counting under a dark-field
light microscope . Various degrees of crenation or cupping of shapes could be
identified. Therefore, for simplicity, only the percent of disc cells was calculated
and presented in the figures. At least 200 cells were counted for each determi-
nation in a blind fashion . Counting variations (of the same sample) were found
to be small, within 3-5%. However, variations in the recovery rates of 20-30%
were occasionally observed between one blood sample and another.
RESULTS
The Recovery of DNP- and PBA-treated
Erythrocytes from Crenation to Disc Shape
When cells were treated with DNP, they became immedi-
ately crenated (Fig. 1 B), and the extent of crenation was a
function of DNP concentration (Fig . 2, 0 h) . When these
treated cells were incubated withDNP at 37°C in the presence
of glucose, a slow, time-dependent recovery from crenation to
normal disc shape was observed at all DNP concentrations
(Fig. 2 and Fig. 1 C and D) . In an attempt to study the
mechanism that allowed cells to restore their original shape,
we considered first the possibility that after long incubation at
37°C, DNP became gradually inactive (as a crenating agent)
and, as a result, recovery of the disc shape occurred . This
possible explanation was examined as follows : cells were
treated with DNP (1 mM final concentration) and incubated
at 37°C in the presence of glucose . At 0 h, just after the cells
were mixed with DNP, and after 24 h of incubation, aliquots
were removed and centrifuged at 12,000 g for 3 min. The
abilities of the resulting supernatants (containing unadsorbed
DNP) to produce crenation of freshly prepared erythrocytes
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FIGURE 2
￿
Time-dependent recovery of cells from crenated to disc
shape, in the presence of DNP. Cells were mixed with various
concentrations of 2,4-DNP and incubated at 37 °C. At various time
intervals, aliquots were removed, fixed with glutaraldehyde (as
described under Materials and Methods), and counted . DNP con-
centrations used were 0.4 (O), 0.6 (" ), 0.8 (A), and 1 mM (") .
FIGURE 1
￿
The recovery process of DNP-treated cells as observed with Nomarski differential interference contrast optics. Cells
were incubated in PBS buffer and 10 mM glucose at 37°C in the absence or presence of DNP (0 .6 mM) . At 0, 2, and 12 h, aliquots
were fixed with glutaraldehyde (as described under Materialsand Methods) . (A) Untreated cells, ( B) DNP-treated cells at 0 h, ( C)
DNP-treated cells after 2 h of incubation, and ( D) DNP-treated cells after 12 h of incubation . x 800.
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885were examined after the appropriate dilutions . As seen in Fig .
3, both supernatants were found to have equal potential to
crenate cells, indicating that the prolonged incubation ofDNP
in thepresence of the cells at 37°C did notcauseany detectable
inactivation of this agent . This suggested that the recovery
process could not be explained simply by DNP inactivation
underthese conditions . It was noticed, however, that both DNP
supernatant solutions were slightly less effective as crenators,
compared with theDNP solution alone, which was incubated
under the same conditions in the absence of cells (Fig . 3) .
These results were expected since part of the DNP molecules
were believed to be associated with the erythrocytemembranes
(5) and were probably removed from the DNP solution by
centrifugation, causing a minor, but detectable, reduction in
the DNP content of the supernatant solutions .
If recovery were caused by an action ofDNPor an impurity
in the DNP, then recovery from another crenating agent, PBA,
would not be expected to proceed at the same rate and to the
same extent. (DNP,an uncoupler ofoxidative phosphorylation,
is known to cross the membrane readily whereas PBA does not
[7].) As seen in Fig . 4, recovery from PBA-induced crenation
is very similar to recovery from DNP-inducedcrenation in rate
and extent of recovery. Further, with both the crude and the
recrystallized reagents, superimposable recovery curves were
obtained . It is unlikely that the rates of shape recovery from
two different crenating agents are caused by the same impurity
of the reagents or a similar redistribution of them within the
membrane .
Another possibility is that the recovery is related to mem-
brane oxidation catalyzed by the amphipath, involving dis-
solved oxygen. To test for this possibility, erythrocytes were
incubated with both DNPand PBA in deoxygenated solutions
in a glove box under an argon atmosphere . The anaerobic
incubation conditions, instead ofinhibiting recovery, caused a
slight acceleration in the recovery rate . All the above results
suggested that a membrane alteration, independent of crenat-
ing agent, was responsible for shape recovery.
DNP-recovered Cells Are Desensitized to
Crenators but More Readily Become Cupped
The findings presented above indicate that cells become
progressively desensitized to DNP, since they restore their
biconcave disc shape in the presence ofDNP that is still fully
active as a crenating agent (Figs . 2 and 3) . If this process is
caused by the alteration of membrane components rather than
chemical modification or rearrangement of the drug itself in
the membrane, it is expected that washed erythrocytes (in a
DNP-free PBS) will conserve their desensitized state towards
DNP. As seen in Fig . 5A, DNP-recovered cells after washing
are much less susceptible to DNP-induced crenation as com-
pared with control cells that were incubated in the absence of
DNP and then washed simultaneously . DNP washout effi-
ciency was examined in the presence of 0.6mM [3H]DNP (2 .5
Ci/mol) . When cells were washed just after the addition of
DNP to the cells or after 12 h of incubation with DNP, <0.5%
[3H]DNP could be detected in the washed erythrocyte pellet
after both incubation periods . Desensitization of the cells after
DNP treatment is not restricted to DNP alone, since PBA,
another crenating agent, failed to crenate DNP-recovered cells
but still was active on control cells (Fig. 5 B) . Since recovery
from a crenated form implies an expansion of the internal half
of the membrane bilayer based upon the bilayer couple hy-
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FIGURE 3
￿
Effect of the supernatants obtained from the suspension
of DNP-treated cells on freshly prepared erythrocytes . Erythrocytes
were incubated at 37°C with 1 mM DNP. At 0 h ("), and after24 h
(A) of incubation, aliquots were taken and centrifuged (in a Beck-
man microfuge B for 3 min), and the supernatants were collected
and diluted to the desired DNP concentration (the supernatants
were estimated to have a concentration of 1 mM DNP) . Freshly
prepared erythrocyte suspensions (0 .1 ml each, 5 x 108 cells/ml)
were then centrifuged, and the resulting pellets were suspended in
the appropriate concentration of DNP solutions . A DNP solution,
which was incubated for 24 h at 37°C in the absence of the
erythrocytes (O), was used as the control solution .
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FIGURE 4
￿
Time-dependent recovery of erythrocytes from crenated
to disc shape, in the presence of PBA . Cell aliquots (1 ml) were
suspended in PBS buffer to give 5 x 10 8 cells/ml and centrifuged
for 10 s in a Beckman microfuge B. Thesupernatants were removed
and the pellets were resuspended in 1 ml of PBS buffer (37°C)
containing various concentrations of PBA (0-1001uM) and incubated
at 37°C . At various time intervals, aliquots were removed, fixed, and
counted as described under Materials and Methods. PBA concen-
trations used were 50 ("), 75 (A), and 100pM (A) .
pothesis (5), the shape-recovered cells should be more
"cupped" than control cells after the DNP is washed away.
Although actual cupping was observed only occasionally,
DNP-recovered cells became readily cupped in thepresence of
low concentrations of chlorpromazine (15 LM), which hardly
affected control cells (Fig . 5 C) . This further suggests that
recovery involves an alteration of the membrane state .
Do DNP-recovered Cells Regain Their Original
Sensitivity to DNP?
In an attempt to examine whetherthe observed DNP desen-
sitization of DNP-recovered cells is a reversible process, cells
were incubated at 37°C in the presence ofDNP (0 .6 mM) for
12 h, and their return from crenation to disc shape was fol-
lowed. As seen in Fig. 6, after 12 h most of the cells regained
the biconcave disc shape . Cells were then washed twice and
incubated in DNP-free PBS for an additional period of 12 h .At various time intervals, aliquots were removed and treated
with 0.6 mM DNP. A gradual resensitization process of the
cells to DNP was observed (Fig . 6) . While at 0 h (just after the
cells were washed), DNP did not induce detectable crenation,
2hlater ^-50% of the cellsbecame crenated . Afteran additional
10 h of incubation, almost all cells were as susceptible to DNP
as control cells that were incubated simultaneously under the
same conditions but without pretreatment with DNP . At that
time (12 h after washing), DNP-pretreated cells were found to
be sensitive not only to DNP but to PBA as well and had lost
their hypersensitivity towards chlorpromazine-induced cup-
ping (data not shown).
Adenosine and Guanosine Effects on the
Recovery of DNP-treated Cells
It was previously demonstrated that ATP is involved in the
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FIGURE 5 Retreatment of DNP-treated cells with DNP, PBA, and
chlorpromazine . Cellswere treated with 0.6mM DNPand incubated
for 12 h as indicated in Fig . 1 . Then, cells were washed twice with
DNP-free PBS by mixing 40 pl of cell suspension in 1 ml of PBS at
room temperature and centrifuging for10 s in a Beckman microfuge
B . The resulting pellet was resuspended in 40 PI of PBS buffer
containing the final concentrations of DNP (A), PBA (B), or chlor-
promazine (C) followed by immediate fixation (within 15 s) with
glutaraldehyde (0) . Control cells (without DNP pretreatment) were
treated with various drug concentrations before (O) or after (")
incubation for 12 h .
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FIGURE 6 Time-course of recovery of DNP-treated cells from the
DNP-resistant state . Cellswere incubated in the presence of 0.6 mM
DNP up to 24 h. At various time intervals, aliquots were removed,
fixed, and counted (O) . After 12 h of incubation, a portion of the
cell suspension was removed, washed twice, and incubated in a
DNP-free buffer for an additional 12 h. At the indicated time
intervals, aliquots were removed, treated with 0.6 mM DNP, and
fixed (" ) . Unwashed cells were further incubated in the presence
of 0.6 mM DNP. After 18 and 24 h, aliquots were removed, washed,
and immediately treated with 0.6 mM DNP (A) . Control cells were
just incubated in the absence of DNP. At various time intervals,
aliquots were removed and treated with 0.6 mM DNP
Time (h)
FIGURE 7
￿
Effect of adenosine and guanosineon the shape recovery
of DNP-treated cells . Cells were incubated in the presence of 2mM
DNP and 10 mM glucose (O), with DNP, glucose, and 2 mM
adenosine (" ) or with DNP, glucose, and 2 mM guanosine (A) .
Aliquots were removed at various time intervals, fixed, and counted
as described under Materials and Methods.
maintenance of the normal shape of the erythrocyte. Since
erythrocytes require adenosine base to synthesize ATP, aden-
osine was added to enable the cell to raise its ATP concentra-
tion . Adenosine (up to 2mM) wasfound to have only a minor
effect on the recovery of cell shape (Fig. 7) . Unexpectedly,
when guanosine (2 mM) was used instead of adenosine, a
dramatic increase in the recovery rate wasobserved . Moreover,
when erythrocytes were preincubated with 2mM guanosine (2
h 37°C) andthen exposedtoDNPin theabsence of guanosine
(which was washed away before DNP treatment), a similar
acceleration of their recovery back to normal discs was ob-
served . Guanosine treatment itself did not affect cell sensitivity
to the crenator agents at0h . Sinceguanosine raises erythrocyte
GTP levels (8), it is possible that guanosine or its metabolites
are involved in this shape recovery process.
The mechanism by which PBA- or DNP-treated cells recover
from echinocyte to normal biconcave disc is not clear yet. In
principle, this recovery process may occur as a result of a
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Indeed, it was initially suggested by Hoffman (9) that sponta-
neous recovery of cells in the presence of a sphering agent
occurred when the uptake of the sphering agent by the cells
was complete . Moreover, it was previously demonstrated (10)
that when erythrocytes were treated with methochlorproma-
zine, they were first crenated, but upon incubation at 37°C
they progressively assumed a normal biconcave disc shape . At
that point, when cells were washed with a drug-free buffer, all
of them became cupped. On the basis of the bilayer couple
hypothesis (5), it was argued that methochlorpromazine inter-
acted first with the outer half of the lipid bilayer causing it to
expand relative to the inner lipid bilayer and producing the
observed crenated shape . With time, methochlorpromazine
flipped from the outer to the inner half of the membrane where
it interacted preferentially at equilibrium . A similar kinetic
phenomenon was observed by Matayoshi (7) with pyrenebu-
tyrylcholine (PBC) . Matayoshi was able to establish with flu-
orescence quenchers that the reversal of cremation was corre-
lated with a movement ofPBC away from external quenchers
(presumably into the cell).
The recovery process described here can hardly be explained
on the basis of the hypothetical mechanism of drug redistri-
bution in the erythrocyte membrane at equilibrium since :
(a) The time-scale ofrecovery is different . While the recovery
of rose bengal- (9), methochlorpromazine- (10), and PBC-
treated (7) cells occurs within 20-60 min, the recovery ofDNP-
and PBA-treated cells requires 4-8 h in the presence ofglucose.
(b) DNP- and PBA-recovered cells do not become cupped
upon further incubation after recovery (up to 12 h) and only
few (<I%) become occasionally cupped after the agents are
washed away.
(c) The shape recovery by drug redistribution does not
require the presence of a metabolic energy source whereas the
recovery from DNP Or PBA cremation will not occur in PBS
alone . It is not known, however, whether energy is required to
restructure membrane components or simply to maintain (dur-
ing long incubation periods) the lability in the skeleton needed
for slow passive relaxation to disc shape. Further studies are
required to clarify this point .
(d) No slow, time-dependent interaction of DNP with the
membrane was detected . [3H]DNP could be readily washed
out, and to the same extent (>99.5%), from cells at 0 h or after
12 h of incubation .
Another possibility is that an impurity in DNP orPBS could
cause recovery, but the data are likewise inconsistent with this
possibility . If the impurity is cationic, it would not explain the
data since, after recovery and washing, cells would be expected
to become cupped. If the impurity reacts with the membrane,
the reaction would have to be reversible (see Fig . 6) and would
have to occur on the same time-scale for both DNP and PBA
impurities . This explanation is even more unlikely because
with either crude or recrystallized reagents the same time-scale
for recovery is observed .
It is conceivable that alternative processes may be proposed
to explain this phenomenon . However, the mechanism that is
consistent with our observations and that we favor is that the
recovery from DNP- and PBA-induced cremation involves a
redistribution or alteration of membrane components rather
than an action of the cremating agents within the membrane .
888
￿
RAPID COMMUNICATIONS
Indeed, after recovery the washed cells are resistant to cremating
agents and sensitive to cupping agents without detectable in-
corporation ofthe drug into the membrane . In addition, strong
support for this suggestion comes from the observation that
preincubation with guanosine but not adenosine is effective in
increasing the recovery rate . This indicates that a nucleotide or
other guanosine metabolite may be involved in producing a
relative expansion of the inner surface of the membrane, i .e .,
shape recovery .
Since the recovery from echinocyte to biconcave disc in-
volves only a small, relative change in the membrane area of
<I% (11), it is possible that protein or lipid alterations could
produce such a change in shape . For example, it was suggested
that energy-dependent shape changes in ghosts can be affected
by antispectrin antibodies (10) or that lipid rearrangements
could produce shape changes, based on the correlation between
1,2-diacylglycerol phosphorylation and the conversion from
echinocyte to disc shape (12, 13) . Although preliminary studies
have demonstrated a change in lipid phosphorylation with
recovery (our unpublished results) the exact identity of the
protein or lipid components that are involved in the recovery
process remains to be established .
From these studies it is clear that the cremation of erythro-
cytes by DNP and PBA is reversible . The results presented
here further suggest that this process involves a restructuring
of membrane components . This implies that erythrocytes can
detect alterations in their shape and can set in motion processes
to restore the normal shape . As mentioned earlier, the relative
area ofthe inner and outer membrane surfaces is an important
parameter in determining membrane shape in any cell . Thus,
we believe that these phenomena may play an important role
not only in maintaining the disc shape of erythrocytes in vivo
but also in the control of shape in other cell types as well.
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